Principles for control of non-HCID mpox in the UK: 4 nations consensus statement
A consensus statement outlining principles for the control of non-high-consequence infectious disease (HCID) mpox (monkeypox) in healthcare and other settings in the UK.
Documents
Details
This document outlines strategic aims for controlling non-HCID mpox, assumptions about mpox transmission and biology, and implications for domestic/community, ambulatory care, inpatient healthcare and other residential settings.
This statement has been agreed by the UK public health agencies: UK Health Security Agency, Public Health Scotland, Public Health Wales and Public Health Agency Northern Ireland.
Last updated 25 January 2023 + show all updates
-
Updated in line with HCID derogation of Clade II MPXV (monkeypox virus). Added new section on cleaning and decontamination.
-
Updated strategic aims.
-
Updated text about evidence of pre-symptomatic transmission.
-
Updated to reflect the change in monkeypox clade nomenclature.
-
Amended in line with introduction of highly probable case definition.
-
Updated to reflect changes in management of contacts of a confirmed case of monkeypox.
-
Updated guidance, including information on using a condom after recovering from infection.
-
Updated to reflect HCID derogation of the current outbreak of monkeypox, and changes to active monitoring of contacts.
-
First published.